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Introduction 
 
 
 
State of the art 
People are a ‘motley crew’ in terms of their individual differences, and 
these differences may partly be explained by the diversity in personality 
dispositions. Personality constitutes “psychological qualities that 
contribute to an individual’s enduring and distinctive patterns of feeling, 
thinking and behaving” (p. 8),1 which implies that our personalities are 
fairly consistent across time and situation and make us different from each 
other.  Several personality theories exist, but one that has attracted attention 
in recent decades is a trait theory called the five-factor theory of 
personality, which encompasses five broad and bipolar personality traits: 
Neuroticism, Extraversion, Openness to experience, Agreeableness and 
Conscientiousness.1 People are characterized by the degree to which they 
show these five personality traits in their thoughts, feelings and behaviour.2 
As regards health behaviour, research has shown associations between the 
described personality traits and adherence behaviour, such as adherence to 
medication treatment.3 Because the significance of personality as an 
influential factor in adherence behaviour has not been sufficiently explored, 
meaning that no conclusions can be drawn as yet,4 and because adherence 
to long-term medication treatments is regarded as too low in general,5 
adherence behaviour in relation to personality constitutes the main focus of 
the present thesis.   
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Background 
 
 
 
The five-factor theory  
The five-factor theory (FFT) has its origin in studies of personality traits, 
but seeks to explain the complex interaction between the enduring and 
changing parts of the personality. The core of the FFT constitutes the Basic 
Tendencies and the Characteristic Adaptations and the distinction between 
them. The FFT serves as an overview of a personality system, where 
complex undefined dynamic processes regulate the components in the 
theory. These processes could constitute perceptions, coping or planning, 
but are not specified in the FFT.2 According to the originators, Costa and 
McCrae,2 knowledge from several fields is required to fully explain these 
complex processes. 
 
The personality traits – Neuroticism, Extraversion, Openness to experience, 
Agreeableness and Conscientiousness – could be described as endogenous 
Basic Tendencies that, according to the FFT, are biologically based and 
therefore rather stable in adulthood. The basic assumption of this position 
is that the Basic Tendencies would be more unstable across time if they 
were environmentally influenced.2   
 
In contrast, the Characteristic Adaptations, which are said to be the most 
complex part of the personality system, are plastic, environmentally 
acquired structures, such as beliefs, attitudes, interests and habits, but also 
social roles and interpersonal interactions. These structures change with 
biological maturation, surrounding context or as a consequence of 
deliberate interventions, although some structures are rather constant while 
others are more volatile. The Characteristic Adaptations also refer to the 
ability to respond to the context in terms of adaptation of feelings, 
thoughts, and behaviour in line with personality traits and previous 
adaptations. External influences like cultural norms or life events influence 
the Characteristic Adaptations, which means that there is an ongoing 
interplay between the environment and personality traits that shapes the 
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Characteristic Adaptations and regulates behaviour. There is also a mutual 
interaction between the person and the environment, as people interpret and 
influence the environment in a manner consistent with their personality 
dispositions.2  
 
The Self-Concept is in fact a part of the Characteristic Adaptations, but is 
of such significance that it needs special attention. It contains our 
understanding of ourselves in terms of our view of our own personality and 
identity. People tend to structure their Self-Concept in a life narrative as a 
way of making their life meaningful and unified. The Self-Concept is said 
to change in line with changes in personality traits and social roles.2 
 
If biological bases and external influences are inputs, then Objective 
Biography is the output or mirror reflecting people’s thoughts, feelings and 
behaviour during the life course.2  
 
The five-factor model  
The FFT is built on research on the five-factor model of personality (FFM) 
focusing on stability in personality traits. The FFM, also known as the Big 
Five, represents a hierarchical structure of traits that consists of five broad 
bipolar personality dimensions called Neuroticism, Extraversion, Openness 
to experience, Agreeableness and Conscientiousness, which represent the 
highest hierarchical level.2 Each dimension consists of six facet scales that 
are defined by clusters of interrelated specific traits,6 as illustrated in Table 
1.  
 
Table 1. The personality traits including facet scales.6 
Neuroticism Extraversion Openness to  
experience 
Agreeableness Conscientiousness 
Anxiety Warmth Fantasy Trust Competence 
Hostility Gregariousness Aesthetics  Straightforwardness Order 
Depression Assertiveness Feelings Altruism Dutifulness 
Self-consciousness Activity Actions Compliance Achievement striving 
Impulsiveness Excitement-seeking Ideas Modesty Self-discipline 
Vulnerability to stress  Positive emotions Values Tender- mindedness Deliberation 
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The FFM has its origin in the so-called lexical hypothesis. The idea is that 
descriptions of personality in terms of traits have been encoded in the 
natural languages by laypersons for years and years. The advantage of 
constructing a theory based on the descriptions of individual differences 
from the natural language is that the descriptions can also be understood by 
people in general. As a language contains a considerable amount of 
personality descriptions, a statistical method called factor analysis has been 
used to organize these descriptions into groups of synonyms, which in turn 
could evolve into clusters and eventually into broad personality factors.7 
Factor analysis could be described as a method for data reduction, which 
means that a large number of interrelated variables (for instance personality 
descriptions in a language) could be collapsed into a smaller set of linear 
combinations called factors. In this way, a meaningful structure in the large 
number of correlations is identified and a smaller number of factors are 
found, which cover or summarize the inter-correlations among a large 
number of variables.8 The contemporary FFM is based on the questionnaire 
tradition, which means that the FFM personality traits have been identified, 
singly or in combination, in other personality instruments.7 
 
According to the FFM, the personality traits are influenced by biology to a 
greater extent than by life experiences. Until the age of 30, there is a 
decline in Neuroticism, Extraversion and Openness to experience, and 
similarly an increase in Agreeableness and Conscientiousness.9 Thereafter, 
it is claimed that the personality traits remain rather stable, therefore 
shaping the characteristics of the person for years to come.2 However, the 
described changing trend is said to continue even after 30 years of age, but 
at a much slower rate.9 Moderate changes in the five personality traits after 
30 years of age have recently been reported as follows: Neuroticism scores 
declined up to the age of 80; Extraversion scores were stable until the age 
of approximately 50 and thereafter a reduction was seen; scores on 
Openness to experience had a negative trend all along; scores on 
Agreeableness increased by age; there was an increase in 
Conscientiousness until 70 years of age.10 The FFM personality traits 
appear and function quite similarly in different cultures,11 and in both 
sexes, but women tend to score higher on Neuroticism and Agreeableness 
than men do. There are also some differences in facet scales, for instance 
women are more likely to score higher on Openness to Feelings, while men 
tend to score higher on Openness to Ideas.12 
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Neuroticism 
Neuroticism measures degrees of emotional stability.1 A person scoring 
high on this trait could perhaps be described as a “worrying kind of 
person” with difficulties handling stress and controlling his/her desires.6 
Higher scores on this trait have also been associated with less healthy 
behaviour estimated as wellness behaviours, such as exercise to stay 
healthy and healthy eating, less accident control, such as having a first aid 
kit, and more traffic risk-taking.13 Fewer health habits measured in relation 
to smoking, alcohol and diet habits were practised in both men and women 
with higher scores on Neuroticism.14 Current smoking has been related to 
higher scores on Neuroticism, especially with concurrent low scores on 
Conscientiousness.15 In addition, Neuroticism may influence the perception 
of health, as higher scores have been associated with the perception of poor 
health in the absence of medical symptoms.16 It has also been reported that 
people with high scores on this trait may be more attentive to physical 
symptoms and tend to interpret them as signs of illness,17 which could 
result in frequent complaints of symptoms17, 18 and recurrent health-care 
seeking.17 People scoring low on Neuroticism could be characterized as 
emotionally stable, which entails that they are more likely to be even-
tempered and able to face stressful situations calmly than are people with 
high scores.6 Emotional stability has been associated with longevity.19 
 
Extraversion 
Extraversion estimates the quantity and intensity of interpersonal 
interaction,1 and people scoring high on this trait are likely to enjoy 
socializing in large groups. They could also be described as talkative, 
optimistic and active.6 In contrast, low scorers are more likely to prefer 
small settings or solitude and could be described as reserved and 
independent in disposition. Higher scores of Extraversion have been related 
to perceptions of good health despite the presence of medical problems.16 
Extraversion has also been related to health behaviour. For instance, 
women with high scores were associated with fewer healthy habits 
measured in relation to smoking, alcohol and diet habits than were low 
scorers.14 Higher scores on this trait have also been related positively to 
accident control and wellness behaviour measured as exercising to stay 
healthy and diet restrictions.13 It has been reported that higher scores on 
Extraversion measured in childhood were associated with both alcohol 
use20 and smoking, but also with performing more physical activity in 
adulthood.21 
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Openness to experience  
Openness to experience measures degrees of seeking and enjoyment of 
experiences for their own sake.1 High scorers are more inclined to be open 
in disposition, to like new ideas and unconventional values than are low 
scorers. They may also be curious about the inner and outer world,6 and 
high scores have been associated with risk-taking behaviour.13 It has been 
reported that women scoring high on Openness to experience tend to have 
fewer healthy habits, measured in relation to, e.g., smoking, alcohol 
consumption and eating habits.14 Low scorers tend to prefer the habitual to 
the new and to be conservative. Concerning emotions, low scorers on 
Openness to experience are more likely to be muted in disposition in 
contrast to high scorers, who are more likely to act out their feelings.6   
 
Agreeableness  
Agreeableness involves quality of interpersonal interaction,1 and people 
associated with higher scores on this trait are inclined to be altruistic, 
sympathetic and helpful to others, with a preference for cooperation. 
People on the low end of this dimension may be egocentric, competitive 
and sceptical about other people’s intentions.6 Higher scores on 
Agreeableness have been associated with healthy behaviour such as more 
accident control and less traffic risk-taking,13 but also serve as a predictor 
of a healthy lifestyle, such as less smoking, low alcohol consumption and 
healthy diets.14 In contrast, people scoring low on Agreeableness in 
childhood seem more disposed to less healthy behaviour as adults in terms 
of higher alcohol consumption and, among women, smoking.20 
 
Conscientiousness 
Conscientiousness measures the degree of motivation in goal-directed 
behaviour.1 Higher scores on Conscientiousness have been associated with 
characteristics such as being reliable, scrupulous and punctual, but in its 
extreme with fastidiousness, compulsive orderliness or workaholic 
behaviour. In comparison, people scoring low on this trait tend to be more 
relaxed when it comes to achieving goals and to be less organized and 
somewhat lazy.6 Conscientiousness has been associated with health 
behaviour, such as better wellness behaviour, more accident control and 
less traffic risk-taking.13 Higher scores on this trait have also been 
associated with a healthy lifestyle,22 such as not smoking, healthy eating 
and engaging in physical activity.14 Additionally, Conscientiousness has 
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been associated with longevity.19, 23, 24 Conscientious children seem less 
inclined to be smokers and to have high alcohol consumption as adults.23 In 
contrast, lower scores on Conscientiousness in childhood have been 
associated with smoking and poorer self-reported health in adulthood.20  
 
Clinical use of the FFM 
Clinical use of the FFM has primarily been related to psychotherapy. It has 
been claimed to be useful in that context, partly for achieving a better 
understanding of patients´ problems and partly for adapting treatment in 
line with specific needs.25, 26 Furthermore, the FFM is suggested to improve 
our understanding of patients´ obstacles and possibilities and thereby to 
make predictions about treatment outcomes.26, 27 It has also been proposed 
that matching different personality traits with different treatment 
approaches would result in better health outcomes.28 Personality traits 
could also be useful when predicting health behaviours such as adherence 
to treatment. In this respect, personality traits could both give rise to an 
increased understanding of the behaviour and serve as a guide to 
identifying different types of needs when planning interventions.6  
 
Perspectives on the FFM 
One advantage of the FFM is that it provides a coherent and handy 
taxonomy of individual differences based on a strong foundation of 
objective data gathered in diverse samples, through both self-reports and 
observer ratings.1 However, it has been argued that individual differences 
exist that are not covered by the FFM taxonomy. There are arguments 
stating that personality dispositions associated with honesty-humility have 
been overlooked. Therefore, the trait Honesty-humility has been suggested 
as the sixth personality trait.29  
 
Other criticism is related to the so-called person-situation controversy, 
which proposes that there is an inconsistency in trait-related behaviour 
from situation to situation. A person could show behaviour congruent with 
high scores on one personality trait in one situation, but show incongruent 
behaviour on the same trait in another situation. For that reason, it has been 
suggested that the situation or context needs to be incorporated into the 
assessment of personality.30  
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The longitudinal stability in adulthood has also been questioned, and it has 
been reported that scores on Conscientiousness31 and Agreeableness 
actually continue to increase with age.31, 32 Another criticism is that the 
FFM does not include dynamic personality processes and is merely focused 
on population-based individual differences instead of individual-level 
differences.1   
 
One strength of the FFM is its wide range of application as a way of 
assessing stable individual differences,1 for instance in health research.23, 33, 
34
 In regard to this type of research, the FFM has been described as 
advantageous because it does not include any health-related items that 
could interact with investigated health factors.13 It has also been argued that 
the primary focus of the FFM is on descriptions of personality and not on 
explanations of associations between personality and health. In addition, 
the FFM does not include any clear cognitive perspective, as do social 
learning theories. For these reasons, it has been suggested that health 
research would be more comprehensive if it combined the FFM with other 
contemporary psychological theories and research.35 From an integrative 
personality perspective, it has been said that an unmet need exists for a 
comprehensive personality theory, which could provide a holistic 
perspective on human personality. Hence, the idea of a new Big Five that 
incorporates personality traits in conjunction with human nature, culture, 
life narratives and characteristic adaptation has been introduced.36 
 
Adherence   
The concept  
Compliance 
The verb comply means to “act in accordance with a wish or command” 
and its etymological origin is the Latin word “complere”, which means to 
fulfil. The noun compliance means “the action or fact of being compliant” 
and the adjective compliant means “disposed to agree with others or obey 
rules, especially to an excessive degree, acquiescent” (p. 293).37 Haynes38 
defined compliance as “the extent to which a person’s behaviour (in terms 
of taking medications, following diets, or executing lifestyle changes) 
coincides with medical or health advice” (p. 1). Both these descriptions 
have a paternalistic undertone as to the relationship between a professional 
who prescribes expert advice and a dependent patient,39 who is expected to 
passively and obediently follow it.40 Because of this unequal relationship 
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and lack of consideration for patients’ initiative, it has been proposed that 
compliance needs to be reconceptualized in favour of regarding the patient 
as an active partner in his/her own health care.39  
 
Adherence 
The concept of adherence has been launched as an alternative to 
compliance. It constitutes an attempt to highlight the fact that the patient is 
free to decide whether to adhere to the prescriber’s recommendations and 
that a decision not to adhere should not result in blaming the patient. The 
concept “adherence” develops the definition of compliance by emphasizing 
the need for an agreement between the prescriber and the patient.41 The 
definition of adherence used by the World Health Organization (WHO) is, 
“the extent to which a person's behaviour  – taking medication, following a 
diet, and/or executing lifestyle changes – corresponds with agreed 
recommendations” (p. 3).5   
 
It has been claimed that no semantic difference exists between the two 
concepts compliance and adherence, although adherence is supposed to 
include a negotiation between the patient and the prescriber.42 The 
etymological origin of the verb adhere is the Latin “adhaerere”, which 
means “to stick” and to adhere means “stick fast to, believe in and follow 
the practices, represent truthfully and in detail”. The noun adherent is 
“someone who supports a particular party, person, or set of ideas” and the 
adjective means “sticking fast to something” (p. 16).37 A concept analysis 
of adherence reported that the concepts adherence and compliance were 
used interchangeably in the literature. It was also reported that different 
definitions of adherence existed, but none included a patient-centred 
approach characterized by taking the patient context into consideration, and 
that the potential power imbalance between the patient and the prescriber 
was disregarded.43  
 
Concordance 
The etymological origin of concordance is the Latin word “concordant, 
concordare”, which means to “agree on” and its semantic meaning today 
is “agreement or consistency” (p. 297).37 In the context of following 
medication prescriptions, the concept was first coined by Marinker et al.,44 
as a result of a collaboration between representatives in a working party 
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from the Royal Pharmaceutical Society of Great Britain and patients’ 
organizations and their effort to act on non-adherence. In this context, the 
idea of a new form of therapeutic relation between patients and physicians 
was born – concordance. The aim of this concept is “to optimise health 
gain from the best use of medicines, compatible with what the patient 
desires and is capable of achieving” (p. 12).42 The basic idea is that the 
meeting between the patient and the prescriber is like a meeting between 
two sets of equally important health beliefs. The patient’s task is to 
describe his/her beliefs and the prescriber’s is to make these beliefs 
possible. The prescriber’s task is to describe his/her beliefs from a 
professional point of view and the patient’s is to consider these. This 
strategy is intended to guide patients in making informed choices, as 
regards their diagnosis and treatment. Concordance recommends a mutual 
relation between the patient and the prescriber, in which the patient makes 
the decision. It is emphasized that concordance does not mean that 
scientific evidence should be disregarded.42  
 
The behaviour 
Adherence behaviour has historic wings. Perhaps the first and most famous 
description of adherence behaviour stems from the Judeo-Christian 
tradition, when Eve ate the apple from the tree of knowledge in the Garden 
of Eden, despite having been advised not to. In ancient Greece, Hippocrates 
realized that patients did not always follow treatment recommendations.38 
Today adherence is a well-studied health behaviour, but perhaps the least 
well understood. Despite decades of research, the dilemma of insufficient 
adherence to prescribed treatment in relation to chronic disease still 
remains, and much is left to be learnt.40, 45 It is common knowledge that 
adherence to long-term medication treatment in chronic disease is 
unsatisfactorily low. It is estimated that adherence to prescribed treatment 
in developed countries is 50%, but even lower in developing countries.5  
 
The WHO recognizes insufficient adherence as a substantial problem and 
states that improving adherence would have a more beneficial impact on 
health outcomes than would the improvement of specific treatments.5 
Deviating from a prescribed treatment may mean that an expected effect 
will fail to appear, with risk for consequences such as worsening of the 
health condition or inability to evaluate the effectiveness of the treatment.40 
Insufficient adherence may be described as a chain reaction, where poor 
adherence to prescribed treatment leads to unmet treatment expectations5 
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with inadequate disease control as a consequence,46-50 which in turn could 
lead to both direct costs related to an increase in utilization of health care51, 
52
 and indirect costs related to the person, such as impaired functioning and 
disability53 and a reduction in productivity.40 Even so, striving for 
enhancing medication adherence could be regarded as working with patient 
safety in terms of minimizing the risk for negative consequences of 
suboptimal adherence, such as increased risk for severe relapse, 
dependency, or a rebound effect.5  
 
Factors influencing adherence behaviour 
Thanks to the large body of research published during recent decades, 
several factors have been identified with regard to their influence on 
adherence behaviour. Thus far, it has been difficult to conclude which 
factors are of most significance and how these interact in influencing 
adherence behaviour.40 WHO has structured recognized influential factors 
into five dimensions: social/economic, therapy-related, patient-related, 
condition-related and those related to the health-care team and system.5  
 
The influence of social/economic factors could pose challenges to 
treatment adherence,5, 54 but their effect on adherence shows an inconsistent 
pattern5 and seems to vary by sample.55 Low level of education, 
unemployment, unstable living conditions are some factors that5 together 
with low income could constitute a risk for low adherence5, 53 in terms of 
unfilled prescriptions or intake of lower doses than prescribed in order to 
economize.53 Nevertheless, the opposite situations are also seen, as low 
adherence to medication treatment does occur among people with a high 
income and high adherence occurs among people with a low income.53 
Another aspect is older adults who may have limited economic resources to 
remain in a treatment due to the reductions in income that come with 
retirement.54 Note that older adults are the highest consumers of medication 
due to the prevalence of multiple chronic diseases in this group.5 WHO 
states that low adherence is found in all age groups and that the research 
evidence is inconsistent. Therefore, it has been recommended that the 
significance of age in relation to adherence be contextually determined.5 
Level of education is yet another factor that could effect adherence, as 
lower levels of education have been related to lower adherence.54 However, 
interventions aimed at improving patients´ knowledge of their medication 
treatment do not always result in the expected outcome.53 As regards 
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differences between men and women in relation to adherence, it has been 
reported that there is no evident difference in adult samples.55  
 
Therapy-related factors, for instance complexity of treatment regimen5 or 
concerns about side effects,56-58 could have a negative impact on adherence. 
Despite efforts on the part of pharmaceutical companies to develop 
medication treatments intended to facilitate adherence, such as medications 
with fewer side effects or combination therapies, it has been claimed that 
these efforts do not appear to be reflected in increased adherence figures.53 
A review on the topic reported that a reduction in daily doses was more 
likely to increase adherence to some medication treatments, but was not 
effective as a general measure.59  
 
Patient-related factors are those related to individual resources, motives, 
attitudes or beliefs,5 which can give rise to two sorts of non-adherence 
behaviour: intentional non-adherence and unintentional non-adherence.41 
The intentional variant is grounded in a conscious decision to deviate from 
the medication treatment.41, 60 Beliefs about medication are most likely to 
play a significant role for this type of adherence behaviour. People who 
express beliefs that the prescribed medication is necessary for their health 
are less inclined to deviate from the prescription, while those who are 
concerned about side effects or becoming dependent are more likely to 
display intentional non-adherence.61-64 Perceptions of illness could also 
influence adherence to medication treatment. For instance, people who do 
not perceive their asthma to be a chronic condition seem more inclined to 
refrain from the medication treatment.65 Unintentional non-adherence 
refers to a willingness to adhere to agreed treatment, but this inclination 
fails due to factors such as forgetfulness or incorrect inhaler technique.41, 60 
Well-integrated routines for medication intake seem to be a necessity if this 
type of non-adherence behaviour is to be avoided.66, 67  
 
One condition-related factor to consider in relation to adherence behaviour 
is self-perceived disease severity.68, 69 People who perceive their condition 
as severe seem more inclined to be adherent.68 It has also been reported that 
people who categorize their asthma as being of high severity seem more 
inclined to overuse their medication.69 Comorbidity is another factor to 
consider. Depression54, 58, 70, 71 and the cognitive impairments that 
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sometimes accompany this condition could lead to difficulties in 
remembering or adhering to treatment recommendations.54  
 
The final dimension refers to the responsibility of the health-care team and 
system-related factors,5 such as the interaction between the health-care 
professional and the patient, which is regarded as important for 
adherence.54 Adherence is a multi-faceted behaviour, which requires 
sufficient resources in terms of health-care staff having the time and ability 
to promote this behaviour.72 It also requires that health-care professionals 
have sufficient knowledge of adherence and effective interventions.5 
Interventions that both increase adherence and improve treatment outcomes 
have been described as complex in that they incorporate an array of 
strategies, but they still do not seem to result in large improvements.73 
Some examples of strategies – which,  based on empirical evidence, are 
said to improve adherence either as stand-alone strategies or in 
combination with more complex interventions – are increasing adherence 
skills (such as training in how to integrate routines, using medication 
organizers), assessing readiness to initiate treatment, and increasing 
treatment-related knowledge, support and motivation. It is stressed that 
there is no single intervention that fits everyone.40  
 
Adherence behaviour from a philosophical perspective 
Four ethical principles are prominent in health care: the autonomy 
principle, the beneficence principle, the non-maleficence principle and the 
justice principle. The autonomy principle refers to a moral obligation to 
safeguard the values and beliefs of the patient, which stipulates that the 
best interest from a patient point of view is the primary moral 
consideration, as long as it does not adversely affect other considerations. 
The beneficence principle refers to a moral obligation, which is aimed at 
producing benefit for those being served. The non-maleficence principle 
refers to the moral obligation to avoid harm, which when applied to health-
care professionals means providing the best balance of good over harm for 
the patient.74 From a medical perspective, it means preserving health and 
preventing disease and injury, which in the context of adherence advocates 
moral support for deliberate interventions to improve adherence to 
treatment.72 As stated above, interventions to enhance adherence could be 
resource-consuming.73 However, health-care professionals have a moral 
duty to be attentive to patients´ adherence behaviour, which could be 
described as a prima facie duty as it recedes into the background when 
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other duties have higher priority. Consequently, these ethical principles 
could come into conflict with each other, and in such situations health-care 
professionals are obliged to comply with the patient’s preferences without 
jeopardizing their professional knowledge. The prescriber has a moral duty 
to ascertain that the patient is making an informed choice and is aware of 
the consequences. The prescriber’s duty is to promote what is good for the 
patient from a medical perspective, which implies that the prescriber is 
obliged to recommend initiation of the treatment. The transition from 
compliance to adherence reflects the importance of patient autonomy, but 
an extension of the concept that more clearly incorporates the patient’s 
informed choice would be welcomed.72  
 
From a philosophical perspective, we could ask whether patients have a 
moral duty to adhere to a prescribed medication. Patients have autonomy as 
regards accepting or declining a treatment. Therefore, a patient´s choice to 
decline a treatment is not to be labelled non-adherence, even though it 
could be viewed as such from a medical perspective. This is an important 
distinction when defining adherence. It has been argued that not adhering is 
a failure on the part of the patient to live up to his/her ethical duty.75 
According to Kant,76 two types of duties exist: the perfect and the 
imperfect. A perfect duty is predominant and ought to be followed. An 
imperfect duty, on the other hand, allows a certain scope of action owing to 
people’s sometimes limited abilities to fulfil a duty.76 People have a moral 
imperfect duty to take care of their health and to adhere to a medication 
treatment if they accepted it. People also have a moral duty not to lie, 
which implies that both the patient and the prescriber have a moral duty to 
be honest with each other.75 Resnik75 explained that with an ‘ought’ follows 
a ‘can’ and “one cannot have a moral duty to do something that one cannot 
do” (p. 175).75 Thus, patients can have rational reasons for not adhering to 
a previously accepted treatment, for instance if they cannot afford the 
medication or feel worse because of its side effects. Nevertheless, it could 
be argued that the patient has a duty to inform the prescriber.  
 
Adherence in relation to personality traits 
Some previous studies have recognized associations between the FFM 
personality traits and adherence behaviour. Neuroticism has been 
associated with lower medication adherence among patients with multiple 
sclerosis77 and patients with asthma.78 Extraversion has been  positively 
related to adherence to exercise among cancer survivors,79 but negatively 
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associated with adherence to antidepressant medication treatment.80 
Agreeableness has been identified as a positive correlate of adherence 
behaviour in candidates for liver transplantation.81 The personality trait that 
seems to be most frequently associated with adherence behaviour is 
Conscientiousness, which has been identified as a positive influential factor 
for medication adherence in patients undergoing renal dialysis,3 patients 
with HIV82 and patients who have been prescribed cholesterol-lowering 
medications.83 Conversely, Penedo et al.,84 who studied the FFM 
personality traits in relation to medication adherence among patients with 
HIV/AIDS, failed to show any clear associations.  
 
Measuring adherence 
There is no available gold standard for assessing adherence at present.5 It is 
difficult to attain a reliable set of adherence measurements, and a mixture 
of methods is probably preferable. There are several different methods to 
choose among, and these can be divided into indirect methods and direct 
methods.85 
 
Indirect methods 
One common indirect method is the so-called self-report, which usually is 
conducted using questionnaires or interviews about medication use.85 One 
drawback of this method is recall bias40 and social desirability bias,85, 86 
which could result in overestimation of adherence.86 The method has the 
advantage of being cost-effective, and reports of low adherence could be 
regarded as reliable.86 The method of self-reported adherence has been 
evaluated in comparison to more objective measures. One study found that 
self-reported adherence correlated with adherence measured electronically. 
When the adherence scores were dichotomized, high self-reported 
adherence predicted high electronic adherence.87 In contrast, another study 
demonstrated that canister weight and electronic monitoring were more 
reliable than self-report and pharmacy records.88 A meta-analysis 
concluded that self-reported adherence gives a good estimation of 
adherence to medication treatment.89 Electronic monitoring is conducted 
using an electronic device that contains a microprocessor that registers the 
time and date when the pill-box is opened or the inhaler is used.90 The term 
medication measurement means that the pills are counted or the inhalers 
weighed, and what is left is then compared to the prescription. One 
weakness of this method is that it only provides information about the 
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content of the pill-box, but no information about actual medication intake. 
Refill adherence is yet another indirect measure. The idea is that adherence 
is assessed using data on prescriptions, dispensed medication and refills 
from the pharmacy databases. One weakness, though, is that it is 
impossible to know whether the medication has actually been taken.85 
 
Direct methods 
One example of a direct method is biochemical analysis of body liquids in 
order to detect levels of medication, byproducts or markers. This is claimed 
to be the only accurate method of measuring adherence, because it gives a 
direct indication of whether or not the medication has been taken.85 On the 
other hand, it has been argued that it only provides information on recent 
medication intake, but does not provide information on long-term 
adherence behaviour.90 Another example is directly observed therapy. 
When this method is used, observations of each dose must be made, which 
could be in conflict with integrity policies.85 
 
Asthma control 
The ambition of modern asthma treatment is to achieve and preserve 
clinical control, which the Global Initiative for Asthma (GINA, p. 22)91 
defines as: 
• No (twice or less/week) daytime symptoms  
• No limitations in daily activities including exercise 
• No nocturnal symptoms or awakening due to asthma 
• No (twice or less/week) need for reliever medication 
• Normal lung function results. 
 
Well-controlled asthma is thought to be an attainable goal for most people 
with asthma, thanks to today’s asthma medication treatment.91 A published 
study, conducted in Sweden, reported that these goals are not reached and 
that no improvement in asthma control has occurred between 2001 and 
2005.92 Studies performed in other countries have also reported figures 
showing suboptimal asthma control.93-95 Several factors are recognized for 
their association with low asthma control, such as female sex,92, 93, 95, 96 
current smoking,92, 93, 97 high body mass index (BMI),93, 98 high dose of 
inhaled corticosteroids and perceived hyper-responsiveness to increasing 
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numbers of triggers.97 There are indications that discrepancies exist 
between reported asthma symptoms and perceived asthma control,94, 95, 99 
whereas Katz et al.100 showed that greater perceived asthma control was 
linked to less severe asthma. Research shows that good asthma control 
influences health-related quality of life (HRQL) positively.96, 100, 101 To the 
best of our knowledge, the relationship between the above-described 
personality traits and reported asthma control has not yet been explored. 
 
Health-related quality of life 
The prevalence of chronic disease is constantly increasing and related 
treatments need to be evaluated on a personal level. In that respect, 
estimations of HRQL serve as a crucial health outcome, as they capture 
personal perspectives and experiences of everyday life with a chronic 
disease and/or ongoing treatment.102  
 
HRQL in relation to adherence behaviour 
Literature describing the relationship between adherence and HRQL 
appears to be rather scarce. One published study103 failed to show any 
associations between the variables in question; a second study found weak 
associations or what it described as “negligible associations”.104 A third 
study identified associations between two items in an HRQL measure and 
adherence. Participants scoring high on vitality reported lower adherence 
scores, and those reporting less bodily pain were more likely to adhere to 
the prescribed medication treatment.105  
 
HRQL in relation to personality traits 
Self-reports on HRQL may also be influenced by people’s scores on 
personality traits, which has been shown in a small number of studies on 
samples with different health conditions.106-109 According to these studies, 
Neuroticism seems to be negatively related to HRQL,106-109 whereas 
Extraversion seems to be both positively106, 108, 109 and negatively109 related 
to HRQL. Openness to experience has been negatively associated with low 
HRQL as regards social function107, mental well-being106 and physical 
function.107 Higher scores on Agreeableness have been associated with 
better HRQL in regard to physical health.106 As regards Conscientiousness, 
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higher scores were related to better HRQL in one study,107 but another 
study could not show any associations.106  
 
Self-efficacy 
According to Bandura,110 social cognitive theory stipulates that striving for 
control in life is fundamental in human beings. This striving is said to 
permeate most of our actions. A person’s action is the result of what is 
called triadic reciprocal causation, which refers to the interaction between 
behaviour, internal factors such as cognitive, affective and biological 
factors and the environment. This means that human beings are active in 
selecting and shaping their environment, but that their beliefs in their 
ability to do so, their self-efficacy, have an impact on their achievements. 
Self-efficacy can be defined as a person’s confidence in his/her ability to 
handle challenges and stressors in everyday life, and it is therefore likely to 
influence that person’s thoughts, motives, feelings and behaviour. People 
with high perceived self-efficacy are inclined to adhere to healthy 
behaviours. Self-efficacy can be strengthened through deliberate 
interventions to improve an outcome,110 which in fact has been 
demonstrated in relation to various chronic diseases.111-113  
 
Self-efficacy in relation to adherence  
The relationship between self-efficacy and adherence to medication 
treatments in various chronic diseases has previously been described. For 
instance, disease-specific self-efficacy has been reported to be positively 
associated with adherence behaviour in patients with asthma,114 
hypertension,115 rheumatoid arthritis,116 HIV117 and coronary heart 
disease.118 In a study among patients with prescribed diabetes treatment, 
low self-efficacy was associated with lower adherence.56  
 
Self-efficacy in relation to personality traits 
There are very few studies exploring personality traits in terms of the FFM 
and self-efficacy in concert. In a study performed by Williams et al.,119 
Neuroticism predicted poor self-efficacy, while Extraversion had a positive 
impact on self-efficacy. Franks et al.120 found that study participants with 
various chronic diseases who reported high scores on Neuroticism and/or 
low scores on Conscientiousness, Agreeableness and Extraversion 
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managed to increased their self-efficacy after having participated in a 
customized intervention. This intervention aimed at strengthening self-
efficacy through several self-management tasks of importance when living 
with a chronic disease.  
 
Rationale  
The significance of personality traits in relation to adherence behaviour, 
asthma control, HRQL and self-efficacy is not completely unexplored, but 
it does not seem possible to draw any conclusions as yet, which inspires 
further research in this field. Despite the large body of adherence research 
in recent decades, adherence to medication treatment seems to remain 
suboptimal. Asthma control, which is the goal of today’s asthma treatment, 
is apparently not being achieved, despite the available medication 
treatment. Reports of experienced asthma control and HRQL may be 
shaped by the influence of different personality traits, but research on this 
aspect is limited. Looking at personality in relation to the other described 
variables in concert could result in a deeper understanding of specific 
personal resources and needs, which could be beneficial when planning 
interventions for use in clinical practice.  
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Aims of the thesis 
 
 
 
The overall aim 
of this research project was to explore the significance of personality traits 
in relation to adherence to medication treatment and asthma control, health-
related quality of life and self-efficacy.  
 
The specific aims were:  
 
I. first to determine whether personality traits in young adult 
asthmatics are related to asthma control and HRQL, and second to 
examine the influences of personality traits on adherence to regular 
asthma medication treatment.  
 
II. to determine whether a relationship exists between FFM personality 
traits and reported adherence to medication in a random population 
of adults aged 30-70. 
 
III. to elucidate adherence reasoning in relation to asthma medication.  
 
IV. to explore the function of self-efficacy and adherence as mediators 
for the influencing effect of personality traits on health-related 
quality of life in persons with chronic disease.  
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Method 
 
 
 
Participants 
Study I and Study III 
This sample consisted of young adults with asthma born between 1984 and 
1986. They were selected from a previous epidemiological study.121 In 
Study I, participants were invited to take part through mailed informational 
letters including questionnaires. The response rate was 73.3%. In Study III, 
18 participants were invited through telephone calls combined with mailed 
informational letters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Sampling procedure in Study I and III.  
 
Total study sample 
792 
 
Unreturned questionnaires 
120 
Declination of participation 
92 
 
Completed questionnaires 
580 
 
Reported asthma remission 
312 
 
Reported asthma 
268 
Study Group 2 
 
No prescribed regular asthma 
medication + missing data 
159 
 
Regular asthma medication + 
completed adherence 
questionnaire 
109 
 
Interview study  
18 
 
 
Study I 
 
Study III 
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Study II and Study IV 
This sample consisted of participants born in 1939-1979 selected at random 
in two municipalities in western Sweden. Contact information for eligible 
participants was provided by the Swedish population register. The 
participants were invited through an informational letter together with 
questionnaires sent by mail. Two reminders were sent to non-responders. 
Finally, 2001 questionnaires were returned, giving a response rate of 
40.0%. A non-response study based on a random sample was conducted by 
telephone. The participants answered eight standardized questions from the 
origin questionnaires including five items from the personality 
questionnaire.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Sampling procedure in Study II and IV.  
 
 
 
Declined participation 
62 
 
Eligible participants 
4938 
 
Unreturned questionnaires 
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Completed questionnaires 
2001 
 
 
Not completed the adherence 
questionnaire  
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Chronic disease + completed 
adherence questionnaire 
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Study II 
 
Total study sample 
5000 
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Study IV 
 
Not diagnosed with chronic 
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1215 
 
Non-response sample 
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Unreachable 
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Declined 
28 
 
 
Non-response study 
56 
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Data collection 
Questionnaires  
The questionnaires described below were used to collect data on 
personality, adherence and asthma control, HRQL and self-efficacy. The 
questionnaires were all constructed so that the participant was required to 
decide to what extent each statement was relevant to him/her.  
 
The Health-relevant Personality 5 factor inventory (Study I) 
The Health-relevant Personality 5 factor inventory (HP5i) was used to 
measure five health-relevant facets of the FFM personality traits: Negative 
Affectivity (as a facet of Neuroticism), Hedonic Capacity (as a facet of 
Extraversion), Alexithymia (as a facet of Openness to experience), 
Antagonism (as a facet of Agreeableness) and Impulsivity (as facet of 
Conscientiousness). This inventory contains 20 items, four for each health-
relevant facet, ranging from “does not apply at all” to “applies completely” 
scored 1-4, from which a mean value is calculated. The HP5i was 
constructed to meet the need for a very short personality inventory for use 
in large-scale or cohort studies.122 It should be clarified that Alexithymia, 
Antagonism and Impulsivity represent health-relevant facets at the opposite 
ends of the personality traits Openness to experience, Agreeableness and 
Conscientiousness. The Cronbach´s alpha values for the HP5i ranged 
between 0.62 and 0.72 for Study I.  
 
The Neuroticism, Extraversion and Openness to experience 
Five-Factor Inventory (Study II and IV) 
A Swedish version of the widely used Neuroticism, Extraversion and 
Openness to experience Five-Factor Inventory (NEO-FFI), which assesses 
the five personality traits according to FFM, was used. The NEO-FFI 
contains 60 items, 12 per personality trait,6 with response alternatives 
ranging from “strongly disagree” to strongly agree”, scored 0-4. The 
Cronbach’s alphas values for the NEO-FFI ranged between 0.69-0.87 for 
Study II and IV.  
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The Medication Adherence Report Scale (Study I, II and IV) 
Adherence behaviour was measured through self-report on the Medication 
Adherence Report Scale (MARS). The MARS contains five statements, 
representing different adherence behaviours, each with five response 
alternatives ranging from “always” to “never”, scored 1-5 with a total score 
of 25. The higher the score, the better the adherence.65 The MARS has 
previously been used in samples with chronic disease and has shown good 
internal reliability.123-125 After having received permission from the 
originator of the MARS, the questionnaire was translated from English to 
Swedish by two native Swedish-speaking nurses. Thereafter the MARS 
was back translated to English by a professional translator who is a native 
speaker of English. This version was sent for approval to the originator 
before permission to use the questionnaire was received. The Cronbach’s 
alpha values for the MARS ranged between 0.71 and 0.81 for Study I, 
Study II and Study IV, respectively.  
 
The Asthma Control Test (Study I) 
The Asthma Control Test (ACT) is a five-item scale for estimation of 
asthma control. Each item was scaled from 1-5, and by summing the 
response values a scale score was calculated ranging from poor (5) to total 
(25) control. A cut-off point of <19 indicates poorly controlled asthma, and 
scores of 20 points or more correspond to well-controlled asthma.126 The 
ACT was developed by Nathan et al.127 and further evaluated in a 
longitudinal study by Schatz et al.128 The Cronbach´s alpha value was 0.75 
for Study I.  
 
The Short Form-8 Health Survey (Study I and IV) 
A Swedish version of the Short Form-8 Health Survey (SF-8) was used to 
evaluate HRQL in relation to both physical and mental well-being. The SF-
8, which is constructed from the widely used SF-36, was developed for use 
in larger samples. The SF-8 contains eight items that measure physical and 
mental HRQL on a five- or six-graded scale, which is transformed to a 
scale of 0-100. The physical dimension, which could be collapsed into a 
physical component score (PCS), consists of: physical functioning, role 
limitations due to physical problems, bodily pain and general health. The 
mental dimension, which could be collapsed into a mental component score 
(MCS), consists of: vitality, social functioning, role limitations due to 
emotional problems, and mental health.129 The component scores PCS and 
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MCS were used in the present studies. The Cronbach´s alpha values for 
PCS were 0.83 and 0.86 and for MCS 0.82 and 0.85 for Study I and Study 
IV, respectively.  
 
The Perceived General Self-efficacy Scale (Study IV) 
The General Self-Efficacy Scale (GSE) measures people’s self-belief in 
their ability to handle difficult demands in everyday life. GSE consists of 
10 items, each with four response alternatives ranging from “not at all true” 
to “exactly true”, scored from 1-4.130 The GSE has been translated and 
tested across cultures, with Cronbach’s alpha values ranging between 0.75 
and 0.91,131 which could be compared to the Cronbach’s alpha value for 
Study IV, which was 0.84. The GSE has been used in samples with various 
chronic diseases132 and has also been studied in relation to the FFM 
personality traits.133 
 
Interviews  
In Study III, the data were collected through interviews and according to 
Grounded Theory (GT) methodology.134 The initial interviews were 
performed in a rather unprejudiced fashion starting with an open-ended 
question about medication intake that was followed by probing questions. 
This approach was used to avoid steering the interviews in a given 
direction. Gradually, the interviews became more systematic so as to 
enable comparisons with the ideas emerging from the analysis. The 
interviewer still strived for a flexible stance to permit new events and 
directions in the interviews. Directly after an interview, a memo was 
written to document the interviewer’s instant impression of the collected 
data. The interviews lasted on average 45 minutes; they were recorded 
digitally and transcribed verbatim.  
 
Analyses 
Study I 
The Statistical Package for the Social Sciences (SPSS) 15.0 was used to 
calculate descriptive statistics (frequencies, means and standard deviations) 
and t-tests for comparisons of means between groups. Pearson’s correlation 
coefficient (r) was used for correlations between interval variables and 
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Spearman’s r for correlations including an ordinal variable. Multiple 
regression analyses were performed to make predictions concerning the 
mental and physical component of HRQL. The variables physical activity 
and smoking were transformed into dichotomous variables (0 = no, 1 = 
yes) in the regression analyses.135 Multiple regression with spline 
function136 was used to make estimations of associations between the HP5i 
and the MARS.  
 
Study II  
In the main study (n=749), descriptive statistics, including frequencies, 
percentages, means and standard deviations, were calculated for all scores. 
Differences in socio-demographic variables, personality and adherence 
scores between men and women were analysed with Fisher’s permutation 
test. Univariate associations between personality traits and adherence 
behaviour were tested using Pitman’s permutation test.137 Non-linear 
relationships between the dependent variable in the MARS and the 
independent predictors (personality traits) were estimated by multiple 
regression with a spline function.138 Means of personality traits, adherence 
scores and age were compared using Student’s t-test. In the non-response 
study, non-responders were compared with the original sample (n=2001) 
by using the Chi-square test, Mann-Whitney test, and Student’s t-test.139  
 
Study III 
The sampling procedure and analysis of the interview data were performed 
in accordance with GT methodology.134 The computer-based program 
NVivo was used to handle and organize the data.140 The analysis was 
carried out through a constant comparison of data, with a focus on 
similarities and differences among ongoing processes. This part of the 
analysis resulted in codes, which were organized into preliminary 
categories and named with respect to meaning of content. The preliminary 
categories were tested as regards dimensions and properties during the 
following interviews. The subsequent focused coding identified variation in 
adherence motives, which needed a proper explanation. At this point, 
appropriate literature was consulted to stimulate creative thinking,134 which 
led us to Higgins’s theory of self-regulatory focus as a motivational 
principle.141 The theory – including the two systems prevention and 
promotion foci – was regarded as containing the overlooked and missing 
parts needed to develop the refined categories we called “promotive focus” 
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and “preventive focus”. The final category, ”permissive focus”, could 
perhaps be seen as an extension of Higgins’s theory141 because it was based 
on data that did not fit into that theory. The subsequent axial coding 
resulted in the creation of subcategories related to the three categories. As 
“illness control” seemed to be fundamental to adherence behaviour, the 
theoretical sampling was concentrated on discovering aspects of this 
concept, which resulted in the emergence of the core category: “A 
functional asthma day as desired by the person”.  
 
Study IV 
Besides descriptive statistics, Pearson’s correlation coefficient was 
calculated using SPSS version 17. Two path models for each personality 
trait were constructed, in which the correlation between two variables was 
calculated as the sum of the compound paths connecting these two points. 
A correlation between two variables is termed indirect or mediated if it is 
dependent on the presence of an additional variable. The analyses were 
performed using the statistical modelling program Mplus version 5142 
together with STREAMS,143 which is a structural equation modelling 
environment. The personality traits were regarded as independent variables, 
GSE and MARS as mediators and PCS and MCS as dependent variables.  
 
Ethical considerations  
Approval was granted by the Regional Ethical Review Board at the 
University of Gothenburg (dnr: 486-06, dnr: 560-08). Ethical principles 
based on the Helsinki declaration were followed. All participants received 
written information about the aim and utility of the studies. In the interview 
study and in the non-response study, the participants also received the same 
information verbally. All participants in the interview study gave their 
written informed consent. The participants were informed that all 
information they gave would be handled confidentially and that no 
information would be traceable to a single individual. The participants 
were also informed that they could withdraw from the study at any time 
without stating a reason.  
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Findings 
 
 
 
Study I 
Findings in Study Group 1 (n=268) 
The sample consisted of 165 (61.6%) women and 103 (38.4%) men aged 
22 (+/-1 year). In general, the participants reported that their asthma was in 
control (mean 21.34, SD 3.73), with no difference between women and 
men. As illustrated in Table 2, two of the five personality traits were 
associated with asthma control. Participants scoring high on Negative 
Affectivity or Impulsivity were associated with reports on lower asthma 
control. Moreover, both the physical and the mental dimension of HRQL 
were positively associated with asthma control. In addition, both Negative 
Affectivity (r=.125, p<0.05) and Impulsivity (r=.213, p<0.001) were 
positively associated with smoking.  
 
 
Table 2. Correlates of asthma control. 
 
 
 
 
 
 
ACT= Asthma Control Test 
MCS=Mental Component Score 
PCS=Physical Component Score 
n.s=non-significant 
 
 
A multiple regression model (F =27.820, p<0.001) explaining 43% of the 
variance in MCS (Adjusted R2 = 0.426) identified Negative Affectivity, 
Impulsivity and smoking habits as negative predictors of the mental 
Variable ACT p-values 
Negative Affectivity -.287   0.001  
Hedonic Capacity  .079   n.s 
Antagonism -.092   n.s 
Alexithymia -.007   n.s 
Impulsivity -.152   0.05 
MCS  .288   0.001 
PCS  .465   0.001 
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dimension of HRQL. Alexithymia, Hedonic Capacity and asthma control 
were identified as positive predictors of the mental dimension of HRQL. In 
a model (F=20.333, p<0.001) explaining 24% of the variance in PCS 
(Adjusted R2 = 0.236), asthma control and physical activity were identified 
as positive predictors of the physical dimension of HRQL.  
 
Findings in Study Group 2 (n=109) 
Study Group 2 consisted of 73 (67%) women and 36 (33%) men aged 22 
(+/-1 year). The reported mean score for adherence was 19.04 (SD, 3.89), 
which could be compared with the maximum score of 25. There was no 
difference in reported adherence scores between women and men. Instead, 
participants prescribed an inhaler combining corticosteroids (ICS) and 
long-acting β2-agonists (LABA) reported higher adherence scores (mean 
20.4, SD 3.6) than participants who were prescribed inhalers with separate 
medication treatment (mean 18.1, SD 3.9), (p<0.05). As regards personality 
and adherence, participants high in Impulsivity were associated with lower 
adherence scores (r=-.187, p<0.05). In male participants, negative 
associations were found between adherence and Alexithymia (r=-.369, 
p<0.05) and Antagonism (r=-.368, p<0.05). No associations between 
personality traits and adherence were found in women.   
 
The non-linear associations (Figures a-e in enclosed Paper I) between 
personality traits and MARS scores estimated by the multiple regressions 
with spline function showed that lower scores on Negative Affectivity were 
associated with increases in MARS scores. A clear non-linear association 
between both Hedonic Capacity and Alexithymia in relation to MARS was 
seen, which showed that lower scores on these traits were positively 
associated with MARS scores while higher scores were negatively 
associated with MARS scores. Moreover, indicated negative associations 
between both Antagonism and Impulsivity in relation to MARS scores 
were seen.  
 
Study II 
The study sample consisted of 427 (57%) women and 322 (43%) men with 
a mean age of 53.59 (SD 11.09). They all reported having been diagnosed 
with a chronic disease, and the most commonly reported diseases were 
hypertension (31%), allergic rhinitis (16.4%), depression (13.6%), asthma 
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(11.5%) and diabetes (9.9%). The reported mean score for adherence was 
22.73 (2.94). No difference in adherence scores between men and women 
was found. As illustrated in Table 3, three of the personality traits and age 
were associated with adherence.  
 
Table 3. Correlations between adherence scores (MARS) and personality  
traits and age. 
 
 
 
 
 
 
 
 
 
 
 
* MARS=Medication Adherence Report Scale 
 
 
A multiple regression analysis with a spline function (Figures a-e in 
enclosed Paper II) showed a negative relationship between Neuroticism 
and MARS across the entire scale. Both associations between 
Conscientiousness and Agreeableness and MARS were clearly non-linear. 
Initial scores on both these personality traits were associated with 
increasing MARS scores while higher scores were associated with 
decreasing MARS scores. Further analysis of these findings indicated that 
participants rated high on Conscientiousness but lower on MARS scored 
significantly higher on Neuroticism or reported lower age than those 
scoring high on MARS, as well as that participants rated higher on 
Agreeableness but lower on MARS simultaneously scored lower on 
Conscientiousness or higher on Openness to experience compared to those 
scoring high on MARS. These findings suggest that high scores on 
Conscientiousness and Agreeableness could be associated with both lower 
and higher MARS scores and that personality traits are interacting in their  
effects on adherence behaviour. Spline functions exploring estimated 
relationships between Openness to experience and MARS revealed that 
lower scores on Openness to experience were associated with slight 
increases in MARS scores, while higher scores were associated with a 
slight reduction in MARS scores. Extraversion could not be regarded as an 
influential factor in relation to adherence behaviour in the present study.  
Variable MARS* p-values 
Neuroticism -0.155        0.001  
Extraversion  0.012        0.30    
Openness to experience -0.064        0.082    
Agreeableness  0.129         0.001  
Conscientiousness  0.162         0.001  
Age  0.238    0.001 
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Data from the non-response study were compared to the whole study 
sample (n=2001). The comparisons showed that study participants reported 
chronic disease to a greater extent than did non-responders, but that there 
were no differences as regards age and education level. Non-responders 
scored higher on Neuroticism, Extraversion and Agreeableness compared 
to participants.  
 
Study III 
The analysis based on data from interviews with 18 young adults with 
asthma emerged in a theoretical model (Figure 1 in Paper III), which 
illustrated that adherence to asthma medication was motivated by three 
foci, promotive, preventive and permissive, which regulated different types 
of medication tactics, all directed towards a desired outcome: “a functional 
asthma day as desired by the person”. A promotive focus was associated 
with the ambition to achieve a positive asthma outcome and regulated the 
medication tactic approaching illness control, which entailed being 
adherent either to the received prescription or to a self-adjusted dosage. A 
preventive focus was intended to ensure avoidance of a negative asthma 
outcome and regulated the medication tactic avoiding uncontrolled illness, 
either by sticking to the prescription or by preventively overusing the 
medication. A permissive focus was aligned with a kind of “let-it-go” 
mentality, according to which everything will turn out fine and regulated 
the medication tactic acting on the spur of symptoms, in which medication 
intake was unstructured and primarily triggered by asthma symptoms.  
 
Study IV 
The participants consisted of 448 (57%) women and 338 (43%) men with a 
mean age of 53.7 (SD 11.1) and with various chronic diseases. The 
findings showed that both general self-efficacy and adherence functioned 
as mediators for the influencing effect of four of the five measured 
personality traits. Self-efficacy mediated the effect of Extraversion (.232, 
T=5.789) and Conscientiousness (.288, T=6.900) on the mental dimension 
of HRQL. Openness to experience had an indirect effect on both the 
physical (.141, T=3.687) and the mental (.379, T=10.608) dimension of 
HRQL through self-efficacy. Adherence functioned as a mediator between 
both Agreeableness (.112, T=2.775) and Conscientiousness (.090, 
T=3.337) on the mental dimension of HRQL. As regards Neuroticism, this 
personality trait had a direct effect on both the physical and the mental 
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dimension of HRQL, but no indirect effect through self-efficacy or 
adherence. 
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Overview of the findings 
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Discussion 
 
 
 
Personality traits, adherence, asthma control, HRQL 
and self-efficacy  
The present thesis has shown that the personality trait Neuroticism seems 
to play a significant role in relation to adherence behaviour and HRQL in 
people with chronic disease. High scorers on Neuroticism seem to be more 
inclined to deviate from treatment recommendations such as adhering to an 
initiated regular medication treatment – a finding that has been supported 
by previous research.77, 78 Furthermore, participants with asthma who 
scored high on Negative Affectivity were more likely to be smokers, which 
is in glaring contrast to treatment recommendations for people with 
asthma.91 The fact that smoking, in turn, seemed to have a negative impact 
on perceived mental HRQL, at least among the young adults with asthma, 
puts additional emphasis on the importance of identifying patients in 
clinical practice who may have some kind of emotional instability, owing 
to the possible increased need for support with disease management among 
these patients.  
 
People scoring high on Neuroticism have been described as being more 
frequent symptom reporters than are more emotionally stable people.17, 18 
This is in line with the reports from participants scoring high on Negative 
Affectivity and Neuroticism in the current studies, who seemed to 
experience both poor asthma control and poor HRQL. This behaviour per 
se need not be negative, because it could lead to early contact with health 
care. In an attempt to identify a possible strategy to support those with 
higher scores on Neuroticism, Study IV sought to show that improving 
adherence and bolstering self-efficacy could be useful in increasing their 
HRQL. This was not successful in relation to Neuroticism. Instead, it was 
obvious that Neuroticism has a greater direct impact on experienced 
HRQL, which indicates that other strategies are needed. As a suggestion, a 
more effective method could be to provide support using strategies to 
tackle emotional expressions. This highlights the need for further studies to 
identify possible useful methods to support the “worrying kind of person”.  
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Based on the studies in the current thesis, Extraversion does not seem to 
have an impact on adherence behaviour in relation to medication treatment 
in chronic disease. To our knowledge, two former studies have presented 
associations between Extraversion and adherence. The first was in relation 
to treatment with antidepressants,80 which indicates that we cannot rule out 
that specific personality traits may have a specific meaning in different 
chronic diseases. The second study found an association in relation to 
exercise adherence,79 which is most likely explained by the fact that people 
who are highly influenced by Extraversion take pleasure in a physically 
active lifestyle.21 In fact, Extraversion was positively associated with 
physical HRQL, which was shown in its direct effect on this dimension of 
HRQL. People less influenced by this personality trait could be described 
as slightly reserved and socially withdrawn.6 As Extraversion also had an 
indirect effect on mental HRQL via self-efficacy, strengthening self-
efficacy in low scorers on this trait could be a useful method of improving 
their mental well-being. 
 
Openness to experience was not associated with medication adherence in 
the present studies. However, young adult men with asthma, who rated 
themselves high on the health-relevant facet Alexithymia, also reported 
lower adherence scores. This finding is in line with a previously published 
pilot study among patients with asthma, which also found a negative 
relationship between adherence and Alexithymia.144 However, this study is 
inconsistent with the present thesis as regards the findings on HRQL and 
asthma control, and this inconsistency may be explained by differences in 
sample characteristics and/or assessments of Alexithymia. Further studies 
are needed in this area.  
 
Moreover, people less influenced by Openness to experience tend to have 
lower self-efficacy, but with reference to the current thesis they could 
improve both their mental and physical HRQL if they managed to 
strengthen their self-efficacy. This underlines the importance of identifying 
these patients in clinical practice. People less influenced by this personality 
trait could be characterized as rather conventional with a preference for 
what is old and proven,6 indicating that it could be a challenge for health-
care professionals to find a suitable intervention. Nevertheless, based on 
the current results, finding such an intervention may be well worth the 
effort. This potential intervention may have to be viewed in the light of 
earlier reports showing that people with higher scores on Openness to 
experience have been associated with risk-taking behaviour13 and less 
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healthy behaviour,14 which could be explained by their increased tendency 
to seek new experiences.6 The present thesis showed that higher scores on 
Openness to experience were related to higher self-perceived self-efficacy, 
which involves having a greater belief in one’s ability to handle challenges 
in life.110 We suggest that these relationships be taken into consideration 
when planning interventions to reinforce self-efficacy. 
 
Another personality characteristic that should be identified in relation to 
disease management is low levels of Agreeableness, as people with low 
scores on this trait seem to be predisposed to lower adherence to 
medication treatment. The health-relevant facet Antagonism was also 
identified as a negative correlate of adherence to asthma medication in 
men. Participants in the present studies who were less influenced by 
Agreeableness also tended to have a propensity for experiencing low 
HRQL. The mental dimension of HRQL might be possible to increase 
through improvements in adherence to medication, because adherence 
mediated the effect of Agreeableness on the mental dimension of HRQL. 
People with low levels of this personality trait may be described as 
antagonistic and sceptical about other people’s intentions,6 which indicates 
that building mutual trust between the patient and the health-care 
professional may be the first priority for a successful outcome.   
 
A person greatly influenced by Conscientiousness could be described as a 
person with “character”, who is predisposed to being orderly, dutiful, 
achievement-oriented and self-disciplined.6 Thus, the conscientious person 
was associated with appropriate disease management in terms of high 
adherence to prescribed medication and with both high HRQL and high 
self-efficacy. In contrast, we suggest that it is essential to recognize people 
at the lower end of this personality trait, because they seem to require 
assistance with their disease management. They reported lower adherence 
and they were also associated with both lower self-efficacy and lower 
HRQL. Impulsivity, as the opposite health-relevant facet of 
Conscientiousness, was associated with low adherence to asthma 
medication and with negative reports on asthma control, HRQL and 
smoking. People less influenced by Conscientiousness tend to be somewhat 
unstructured and aimless in disposition6 and could be assumed to be in 
need of support to integrate routines or to require reminders for their 
medication intake, which could be initiated with guidance from health-care 
professionals. This is of particular interest, as our findings showed that an 
increase in adherence and self-efficacy may have had a favourable effect on 
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mental well-being among our less conscientious study participants. 
Furthermore, it has previously been reported that lower scores on 
Conscientiousness have been related to smoking20 and in Study I the young 
adults with asthma, who scored high on Impulsivity were associated with 
smoking, which not coincides with proper asthma management91 and 
therefore may be viewed as an unmet need of support. 
 
Findings in relation to the adherence concept 
Critical voices have been raised against the concepts of adherence and 
compliance because neither of them includes motivations for encouraging 
the patient to make a decision about his/her medication use – this in 
combination with the unfair categorization of adherers and non-adherers.145 
With reference to the findings of Study III, these voices may deserve 
acknowledgement, as the participants seemed to have been guided by three 
motivational foci, which inspired different medication tactics aimed at the 
goal of having a functional asthma day. All of the participants had adopted 
a conscious medication tactic suitable to achieving their goal with regard to 
intake of asthma medication. From their perspective, it would be 
groundless to label any of them as non-adherent, though such a label would 
be assigned from a medical point of view. To achieve a win-win adherence 
situation, health-care professionals engaged in care of patients with asthma 
or other chronic diseases should focus on empowering patients to make 
informed health choices,146 which could be seen as a moral duty.72 The 
patient’s responsibility is to actively participate in his/her care and to strive 
for a better health outcome,146 which he/she has a moral duty to do,75 and 
this includes adherence to treatment.146 To do this, the patient requires 
health literacy, and promoting this literacy is the responsibility of health-
care professionals.  
 
With further reference to Study III, it is obvious that interventions should 
not solely be aimed at improving adherence behaviour, but they should also 
be linked to an explicit desired outcome defined by the patient. This 
outcome could deviate from that defined by a medical perspective. As an 
example, the young adults said that their desired outcome was a functional 
asthma day, but for a clinician or asthma nurse, the outcome of proper 
adherence to asthma medication treatment could be focused on disease 
progress, which from a patient perspective might seem incomprehensible. 
For this reason, health-care professionals should concentrate on what 
medication tactic the patient is using to achieve a functional day, instead of 
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defining divergent tactics as non-adherence. This position could be viewed 
as a contribution to the debate on the concepts “adherence” and 
“compliance”.  
 
The etymological origin of the word tactic is the Greek word taktikē 
(tekhnē), which means “an action or strategy carefully planned to achieve 
a specific end” (p. 1465).37 Having a medication tactic could enable the 
patient, with support from health-care professionals, to use this tactic to 
achieve the desired outcome of a medication treatment. It takes a tactic to 
achieve a set goal. Not one of the concepts compliance, adherence or 
concordance seems to include such a path towards a set goal. Compliance 
and adherence tend to lead to a dichotomized labelling into: high/low, 
good/bad proper/improper, adequate/inadequate, satisfactory/unsatisfactory 
adherence, while concordance seems to strive towards an agreement 
between the patient and the prescriber in best-case scenarios. When 
different perspectives contrast in the context of health care, the patient’s 
preferences are superordinate when considering the autonomy principle. 
Introduction of the term adherence in favour of compliance underlines the 
significance of patient autonomy. However, a further development of the 
concept is proposed, as the patient’s informed choice is still not included.72 
Reflecting on the beneficence and non-maleficence principles, the 
prescriber has a duty to provide the best balance of good over harm for the 
patient.74 Therefore, the term “medication tactic” could constitute a prudent 
alternative to the other concepts, as it considers both the patient and the 
prescriber perspective.  
 
Methodological considerations 
These four studies are unique in that they are based on an epidemiological 
design intended to explore personality and adherence behaviour. The 
strength of this design is that a random sampling procedure was applied, 
which minimizes the risk of sampling and selection biases.147  
 
Study I was part of a previous epidemiological study, and we conducted a 
follow-up in the cohort of participants who in the initial study had reported 
an asthma diagnosis. In this study, the response rate was considered 
satisfactory. In Study II the study population was estimated to be large 
enough for statistical inference, but the low response rate constituted a risk 
in that respect.147 Despite the low response rate, previously established 
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societal structures like sex differences in the incidence of chronic 
disease148-153 and in Swedish wage statistics154 were found, which was 
considered reassuring, as it increases the likelihood of 
representativeness.135  
 
It has been argued that the number of responders in postal surveys has 
declined in recent years and that non-response analysis is seldom carried 
out.155 This argument is applicable to Study II, which had a low response 
rate. On the other hand, a non-response study was conducted, which is a 
strength.147 The non-response study did not reveal any differences as 
regards age or education level, but the non-responders did report a lower 
frequency of chronic disease than did participants in the original sample. 
This could explain non-participation, as a large proportion of the 
questionnaire items addressed aspects of chronic disease.  
 
As hypothesized, there were differences in personality between non-
responders and participants in the original study. Answering questions 
about disease and related aspects of health could trigger emotional distress 
in individuals rated higher on Neuroticism, and thus for these individuals, a 
reasonable choice would be to refrain from taking part. Higher scores on 
Extraversion indicate a preference for socializing with people,6 which 
could discourage spending time on time-consuming questionnaires. 
Agreeableness was also rated higher among non-responders, which is 
inconsistent with the results of a study exploring the impact of personality 
traits on missing data.156 Persons scoring high on Agreeableness are 
generally prone to please,6 which in fact could explain the finding of the 
referred study on personality traits and missing data. These differences in 
findings could be based on the fact that the present study estimated 
personality using one item and not the entire scale. It is known that 
questions that are perceived as too sensitive and extensive questionnaires 
are both factors that negatively affect response rates.157 The findings of the 
present non-response study were probably reinforced by the influence of 
the personality traits Neuroticism and Extraversion. 
 
An additional strength was that all the participants in Study II and IV were 
above 30 years of age, when the FFM personality traits are considered to be 
fairly stable. The fact that all participants were 22 years in Study I and III 
could constitute a possible limitation, because the personality traits are not 
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thought to be fully stabilized at that age. Conversely, this tight age span 
could help in avoiding age- and generation- dependent effects on the 
findings. No data on asthma severity were collected in any of the studies, 
which could be a weakness, because degree of severity may influence 
adherence behaviour, perceptions of asthma control and HRQL. Another 
feasible limitation may be the method of measuring adherence using an 
indirect measure like self-reports,85 owing to its potential weakness in 
terms of recall bias40 and desirability bias,85, 86 which could result in 
erroneously high scores.86 Due to the study designs, self-report was 
considered the most feasible method of capturing adherence behaviour, 
although it did not provide an exact measure of adherence to prescribed 
medication treatment.  
 
In qualitative research, rigour involves credibility, auditability and 
fittingness. Credibility concerns the trustworthiness of the findings, that is, 
whether the phenomenon under investigation is described in a recognizable 
manner for people versed in the area.158 In Study III, credibility was 
considered by carrying out the initial interviews in a rather unprejudiced 
fashion and letting the participants talk freely about their medication 
intake. Using this approach, the participants directed the interview process 
and were not forced in a given direction. Constant openness was strived for 
during the collection and analysis of the data to achieve a balance between 
theoretical sensitivity134 and reflexivity.159 A constant comparison of data 
was conducted, in that ideas arising from the analysis were reconfirmed 
during subsequent collection of new data. Non-confirmed ideas could 
thereby be discarded. This policy was adhered to throughout the study, also 
in relation to data at more abstract levels, such as formulated concepts and 
categories, which were validated in subsequent interviews.134 Auditability 
refers to the consistency of the study, that is, whether another researcher is 
able to follow the process. In the present study, auditability was considered 
through a careful description of the stages in the process, from selection of 
participants to data collection, and finally to the emergence of the 
theoretical model. Fittingness denotes the usefulness of the findings in a 
similar context. To enable judgment of fittingness, background data on the 
participants were accounted for, such as age and disease duration. It is also 
important to state the level of the generated theory to enable judgment of 
fittingness.158 The theoretical model that was developed on the basis of the 
present data could be viewed as being on the level of a substantive theory, 
because it originates from a very specific context and therefore is not 
transferable to other contexts.134  
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Implications for future studies 
The four studies forming the foundation of the present thesis are 
explorative in design. Thus one implication for future research is to enable 
the development and initiation of interventions based on the present 
findings for evaluation in clinical practice. One priority is to obtain 
accurate estimations of adherence behaviour, but also to identify patients 
who are in need of support with their adherence behaviour and to recognize 
what kind of support they might need. For example, one approach could be 
to intervene in low scorers on Conscientiousness by incorporating routines 
for medication intake to increase their adherence and by estimating effects 
on HRQL.  
 
It has been argued that standardized and valid questionnaires for assessing 
adherence are rarely used in daily practice in clinical settings. Furthermore, 
in the context of clinical practice, it may be difficult to estimate accurate 
adherence level and to identify which patients are likely to deviate from a 
prescribed treatment.85 Therefore, we suggest the development and 
validation of a practical questionnaire for clinical use based on the present 
findings, which both estimates adherence behaviour and identifies patients 
in need of support. Such a questionnaire may facilitate the adherence duty 
for health-care professionals and in turn be beneficial for the patients.  
 
We also propose that the concept of adherence be further analysed and 
studied, as adherence behaviour in medication users is obviously guided by 
other motives than simply following a prescription. Because the theoretical 
model of adherence behaviour in Study III was based on a homogenous 
group of participants, it has limited fittingness. Therefore, understanding 
adherence reasoning in groups of various ages and undergoing different 
medication treatments would seem to be a reasonable approach to 
achieving better explanatory power. Studies of that kind could be of value 
in developing the concept “medication tactics” for clinical use.  
 
In future studies, we recommend that self-reported adherence be combined 
with other more objective methods of monitoring, which result in more 
exact adherence scores.  
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We also propose that interventions to improve HRQL in persons living 
with chronic disease be further investigated, because reinforcement of self-
efficacy and improvement of adherence to medication could be suitable for 
some, but not suitable as a general method.  
 
The interaction of personality traits in relation to adherence behaviour 
deserves a more thorough investigation, the hope being that results might 
make it possible to identify personality profiles that require special 
attention and assistance from health-care professionals.  
 
Clinical implications 
The transition from disease-oriented care to a patient-centred160, 161 or 
person-centred approach162 aimed at shared treatment decisions can be 
assumed to challenge and encourage care-providers to increase both their 
interest in and knowledge of the diversity of personality differences. The 
present thesis offers insights into how different personality traits may 
influence adherence behaviour and perceptions of health outcomes, such as 
asthma control and HRQL. The present findings could help health-care 
professionals increase their understanding of patients’ individual needs, but 
also serve as a guideline for how to approach assisting patients with disease 
management. For instance, a patient greatly influenced by Impulsivity – 
which in Study I was associated with reported poor asthma control, low 
HRQL, poor adherence and smoking– may need a different kind of support 
than a patient less influenced by this trait. 
 
Conclusion 
The present findings show that personality is an influential factor as 
regards adherence behaviour, self-efficacy, asthma control and HRQL. 
Because the stable biological personality dispositions have an impact on 
the Characteristic Adaptations, which in turn include changeable habits and 
attitudes, specifically targeted interventions could influence medication 
habits. These kinds of interventions would seem to be most needed among 
high scorers on Neuroticism and low scorers on Agreeableness and 
Conscientiousness. Supporting less agreeable and less conscientious people 
in their adherence behaviour could also result in a positive outcome in 
terms of their mental well-being. Reinforcing self-efficacy in low scorers 
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on Extraversion, Openness to experience and Conscientiousness could be 
beneficial to their mental well-being.   
 
Overall, the present thesis identifies potential unmet needs in people with 
different personality dispositions and therefore could be viewed as an 
important contribution to the area of person-centred care. One reasonable 
conclusion is that increased knowledge and understanding of how different 
personality traits and motivational factors seem to influence adherence 
behaviour contribute greatly to the development of individually tailored 
approaches and treatment plans, designed to target the specific needs of 
each person, because no single adherence intervention fits everyone.  
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“Stor är människans strävan, 
stora de mål hon satt – 
men mycket större är människan själv 
med rötter i alltets natt.” 
 
(Människans mångfald ur De sju dödssynderna av Karin Boye) 
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Svensk sammanfattning 
 
 
 
Följsamhet med läkemedelsbehandling vid flertalet kroniska sjukdomar 
betraktas generellt sett som låg. Tidigare forskning har identifierat en rad 
påverkansfaktorer, men betydelsen av personlighet anses inte tillräckligt 
studerad. Personlighet kan beskrivas som psykologiska kvaliteter som 
bidrar till bestående och distinkta mönster, vilka visar sig i människors 
tankar, känslor och beteenden. Enligt fem-faktor modellen kan personlighet 
beskrivas mot bakgrund av fem breda, bipolära personlighetsdrag: 
känslomässig instabilitet, utåtriktning, öppenhet, vänlighet och 
målmedvetenhet. Dessa personlighetsdrag utgör den högsta hierarkiska 
nivån och vart och ett av dem är i sin tur uppdelade i sex s.k. facetter 
bestående av mer specifika personlighetsdrag. Avhandlingens övergripande 
syfte var att undersöka betydelsen av personlighet i förhållande till 
följsamhet med läkemedelsbehandling, astmakontroll, livskvalitet och 
tilltro till egen förmåga. Avhandlingen utgörs av fyra studier, vilka 
samtliga vilar på epidemiologisk grund. I Studierna I och III bestod 
deltagarna av unga vuxna, som var 22 år (+/- 1 år) och hade astma. Antalet 
deltagare var 268 i Studie I och 18 i Studie III. Studierna II och IV bestod 
av deltagare i åldrarna 30-70 år med olika typer av kroniska sjukdomar. 
Antalet deltagare var 749 i Studie II och 786 i Studie IV. I Studierna I, II 
och IV skedde datainsamlingen via frågeformulär. När det gäller skattning 
av personlighet användes två olika frågeformulär. I Studierna II och IV 
användes ett frågeformulär som skattar personlighetsdragen i fem-faktor 
modellen. I Studie I användes ett annat frågeformulär, vilket skattar 
hälsorelevanta facetter baserade på fem-faktor modellen. Studie III var en 
intervjustudie, vilken genomfördes enligt Grounded Theory metodologi.  
 
Föreliggande avhandling visar att personlighetsdragen känslomässig 
instabilitet, vänlighet och målmedvetenhet verkar vara särskilt 
betydelsefulla i förhållande till följsamhet med läkemedelsbehandling. 
Känslomässig instabilitet hade ett negativt samband med följsamhet, vilket 
innebär att personer som skattade högt på detta personlighetsdrag 
rapporterade sämre följsamhet. Både vänlighet och målmedvetenhet hade 
positiva samband med följsamhet, vilket innebär att personer som skattade 
högt på dessa personlighetsdrag rapporterade högre följsamhet (Studie II). 
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När det gäller de hälsorelevanta facetterna identifierades negativa samband 
mellan impulsivitet och följsamhet. Dessutom framkom negativa samband 
mellan alexitymi och antagonism hos män och följsamhet, vilket indikerar 
att män som skattade högt på någon av dessa hälsorelevanta facetter 
tenderade att vara mindre följsamma med ordinerad astmamedicinering 
(Studie I). Vidare framkom att följsamhet med astmamedicinering verkar 
regleras av olika kognitiva motiverande fokus: främjande fokus, 
förebyggande fokus och tillåtande fokus. Dessa gav upphov till olika 
medicintaktiker, vilka samtliga syftade till att uppnå en fungerande dag 
med astma (Studie III).  
 
När det gäller personlighet i förhållande till självskattad astmakontroll 
befanns den hälsorelevanta facetten negativ affekt ha ett negativt samband 
med astmakontroll, vilket innebär att personer som skattade högt på negativ 
affekt, skattade sämre astmakontroll. Beträffande mental hälsorelaterad 
livskvalitet, identifierades både negativ affekt och impulsivitet som 
negativa prediktorer, vilket innebär att ju högre personen skattade sig på 
dessa hälsorelevanta facetter desto lägre mental livskvalitet uppfattade sig 
personen ha (Studie I). Därtill visades att både utåtriktning och 
målmedvetenhet hade en indirekt effekt på mental hälsorelaterad 
livskvalitet genom tilltro till egen förmåga. Detta kan innebära att en 
förbättring av tilltro till egen förmåga skulle kunna öka den mentala 
hälsorelaterade livskvaliteten hos personer som skattar lågt på något av 
dessa personlighetsdrag. Vidare skulle såväl den fysiska som den mentala 
hälsorelaterade livskvaliteten kunna förbättras hos personer som skattar 
lågt på öppenhet, genom att stärka deras tilltro till egen förmåga. Den 
mentala livskvaliteten verkar även kunna förbättras hos personer som 
skattar lågt på vänlighet och målmedvetenhet, genom att öka deras 
följsamhet med läkemedelsbehandling (Studie IV).  
 
Föreliggande avhandling identifierar möjliga behov hos människor med 
olika framträdande personlighetsdrag och skulle därför kunna utgöra ett 
betydelsefullt bidrag till utformandet av personanpassade interventioner 
med syfte att utveckla vård och behandling. En rimlig slutsats är att ökad 
kunskap och förståelse om betydelsen av olika personlighetsdrag och 
kognitivt motiverande faktorer i förhållande till följsamhet med 
läkemedelsbehandling och hälsoutfall som astmakontroll och hälsorelaterad 
livskvalitet kan bidraga till utveckling av skräddarsydda behandlingsplaner, 
designade för att tillgodose enskilda personers behov av stöd och tillvarata 
deras resurser.  
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